Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.
Hematological Diseases|Hematological Malignancies|Blood Diseases|Malignant Lymphoma|Leukemia|Multiple Myeloma
DRUG: Bismuth tablets|DRUG: Placebo tablets
To evaluate a possible protective effect of bismuth on the mucous membranes during chemotherapy and radiotherapy, daily during treatment
To identify the effect of bismuth on the regulation of metallothionein in tumour tissue and healthy tissue, respectively, 6 months
The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.